Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-08-16
1999-09-21
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 23, 514 53, 514561, A61K 3170
Patent
active
059554509
ABSTRACT:
Peritoneal dialysis solutions are specially formulated for use during and immediately after an episode of peritonitis. The solutions include one or more additives to minimize the injury and physiological effects that peritonitis can cause. One additive is a mixture of amino acids sufficient to maintain a positive nitrogen balance, at least one of the amino acids being present in a dipeptide form. Another additive is a compound that scavenges free radicals generated by peritoneal macrophages activated by the peritonitis. Another additive is chondroitin sulfate that changes the permeability of the peritoneal membrane during subsequent dialysis using solutions free of chondroitin sulfate. Another additive is the degradation products of hyaluronic acid to enhance the regeneration of the peritoneal mesothelium without fibrosis.
REFERENCES:
patent: 5108767 (1992-04-01), Mulchandani et al.
patent: 5597805 (1997-01-01), Breborowicz
Breborowicz Andrzej
Oreopoulos Dimitrios G.
Barrett Robert M.
Baxter International Inc.
Borecki Thomas S.
Mattenson Charles R.
Peselev Elli
LandOfFree
Peritoneal dialysis solutions and methods usable to minimize the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peritoneal dialysis solutions and methods usable to minimize the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peritoneal dialysis solutions and methods usable to minimize the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80372